Kelly Curtin
Managing Director
BioPharma
London
[email protected] | +44 20 3 465 1202 | v-CardKelly Curtin is a Managing Director in Stifel’s Global Healthcare Group with over 20 years of experience in investment banking, primarily in the healthcare industry. Her experience includes strategic transactions across a wide spectrum of the life sciences, including biotechnology, pharma, specialty pharma, generics, healthcare services, and medical devices. Kelly has led M&A transactions for public and private companies, licensing transactions and divestments as well as executed a range of equity and debt financings. Kelly became part of Stifel in 2023 through the Torreya acquisition.
Before joining Torreya in 2014, Kelly was a Director in Credit Suisse’s Mergers & Acquisitions group in both Chicago and London.
Kelly holds a B.A. in Law, Jurisprudence and Social Thought from Amherst College.